D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide

Clinical and Experimental Rheumatology

Volumn 20, Issue 4, 2002, Pages 469-476

  Harada, Shuji ^a   Sugiyama, Eiji ^a   Taki, Hirofumi ^a   Shinoda, Kouichiro ^a   Fijita, Tadashi ^a   Maruyama, Muneharu ^a   Kobayashi, Masashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Copper sulfate; D penicillamine; Fas mediated apoptosis; Rheumatoid arthritis; Synovial fibroblast

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CATALASE; COPPER SULFATE; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; HYDROGEN PEROXIDE; INTERLEUKIN 1ALPHA; PENICILLAMINE; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; DNA; FASLG PROTEIN, HUMAN; INTERLEUKIN 1; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CELL COUNT; CELL GROWTH; CELL STIMULATION; CELL SURFACE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STAINING; SYNOVIUM; TIME; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; METABOLISM; PATHOLOGY;

ANTIGENS, CD95; ANTIRHEUMATIC AGENTS; APOPTOSIS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CATALASE; CELLS, CULTURED; COPPER SULFATE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; FIBROBLASTS; FLOW CYTOMETRY; HUMAN; HYDROGEN PEROXIDE; INTERLEUKIN-1; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; PENICILLAMINE; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR; FAS LIGAND PROTEIN; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035988612     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rheumatoid arthritis: Pathophysiology and implications for therapy
2. Cellular basis and oncogene expression of rheumatoid joint destruction
3. Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts
4. Cytokine and cytokine inhibitors or antagonists in rheumatoid arthritis
5. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
6. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis
7. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis
8. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA)
9. Apoptosis in rheumatoid arthritis. A novel pathway in the regulation of synovial tissue
10. Azathioprine and penicillamine in treatment of rheumatoid arthritis: A controlled trial
11. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen
12. Outcome of second line therapy in rheumatoid arthritis
13. Reevaluating the therapeutic approach to rheumatoid arthritis: The 'sawtooth' strategy
14. 4
15. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes
16. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine
17. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro
18. Redox regulation of cellular signalling
19. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss
20. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide
21. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
22. Determination of D-penicillamine in serum and urine of patients with rheumatoid arthritis
23. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects
24. Fas antigen expression on synovial cells was down-regulated by interleukin 1β
25. Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts
26. Serum copper and related variables in rheumatoid arthritis
27. Detection and investigation of the molecular nature of low-molecular- mass copper ions in isolated rheumatoid knee-joint synovial fluid
28. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB
29. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-α-tocopherol in vascular smooth muscle cells
30. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability
31. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells
32. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
33. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication
34. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium
35. Role of reactive oxygen intermediates in activation-induced CD95 (APO- 1/Fas) ligand expression
36. Oxidative stress and hypoxia-/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells